Skip to main content

Tracking the Biotech Bounce

Biotech buyouts are coming. But no one’s paying attention… New record highs for stocks are instead sparking refreshed arguments from economists and analysts alike. They want to debate peak valuations or whether or not we’re entering a “Goldilocks economy” where growth is not too hot, not too cold—but just right. But all of the debate […] View the full post at: Tracking the Biotech Bounce Related posts: Leveraged Buyout Revival Seen in Default Swaps: Credit Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.